Company news: Amgen’s (AMGN) quarterly results top analysts’ estimates

Amgen (AMGN) reported Q4 FY2024 earnings of $5.31 per share (versus $4.71 per share in Q4 FY2023), beating analysts’ consensus estimate of $5.08 per share.

The company’s quarterly revenues amounted to $9.086 bln (+10.9% y/y), beating analysts’ consensus estimate of $8.881 bln.

The company also issued in-line guidance for FY2025, seeing EPS of $20.00-21.20 versus analysts’ consensus estimate of $20.92 and revenues of $34.3-35.7 bln versus analysts’ consensus estimate of $34.62 bln.

AMGN fell to $287.25 (-0.61%) in pre-market trading.